14
4
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1181 |
Bradykinin (2-9)
Des-Arg1-bradykinin |
Bradykinin Receptor | GPCR/G Protein |
Bradykinin (2-9) (Des-Arg1-bradykinin),是Bradykinin的一种氨基端截短肽类代谢物,通过Aminopeptidase P的切割作用形成。 | |||
TP1931L1 |
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate(96736-12-8 free base) |
cholecystokinin | GPCR/G Protein |
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate ([D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate (96736-12-8 free base)) 是广谱神经肽反向激动剂和拮抗剂。 ghrelin 受体的强效完全反向激动剂(EC50 = 5.2 nM);减少组成型生长素释放肽受体信号传导。它也是速激肽、缓激肽、CCK 和铃蟾肽受体的拮抗剂。在体外诱导细胞凋亡并抑制癌细胞生长。 | |||
T39932 |
ARG1-IN-1
ARG1-IN-1 |
||
ARG1-IN-1 is a human arginase 1 inhibitor with an IC 50 of 29 nM. | |||
TP1931 |
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P
|
||
Broad spectrum neuropeptide inverse agonist and antagonist. Potent full inverse agonist for the ghrelin receptor (EC50 = 5.2 nM); diminishes constitutive ghrelin receptor signaling. Also antagonist at tachykinin, bradykinin, CCK and bombesin receptors. In | |||
T78656 |
ARG1-IN-1 hydrochloride
|
Arginase | Immunology/Inflammation |
ARG1-IN-1 (example 1) hydrochloride为一种针对人类精氨酸酶1的抑制剂,具有29 nM的IC50值。 | |||
T76446 |
(D-Arg1,D-Pro2,D-Phe7,D-His9)-Substance P
|
||
(D-Arg1,D-Pro2,D-Phe7,D-His9)-Substance P 是一种选择性的 NK1receptor 拮抗剂。 | |||
T76445 |
(D-Arg1,D-Pro2,D-Trp7,9,L-Leu11)-Substance P
|
||
(D-Arg1,D-Pro2,D-Trp7,9,L-Leu11)-Substance P 是神经肽 Substance P 的拮抗剂。 | |||
T83548 |
(D-Arg1,D-Pro2,D-Trp7,9,L-Leu11)-Substance P acetate
|
||
'(D-Arg1,D-Pro2,D-Trp7,9,L-Leu11)-Substance P (acetate)' 是一种对 Substance P 及 Bombesin 担任拮抗作用的化合物,能针对眼部三叉神经反向刺激引起的炎症反应产生效果。 | |||
T83195 |
Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27)
|
||
Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27),是一种血管活性肠肽,起到VIP1受体拮抗剂的作用。 | |||
T75896 |
[Arg14,Lys15]Nociceptin TFA
|
||
[Arg14,Lys15]Nociceptin TFA 是一种高效、选择性的 NOP (ORL1; OP4)受体激动剂,EC50为 1 nM。[Arg14,Lys15]Nociceptin TFA 对阿片受体具有较高的选择性,对 NOP、μ、δ 和 κ 受体的 IC50值分别为 0.32、280、>10000 和 1500 nM。 | |||
TP1986 |
[Arg14,Lys15]Nociceptin
|
||
Highly potent and selective NOP receptor agonist (EC50 = 1 nM). Displays > 875-fold selectivity over opioid receptors (IC50 values are 0.32, 280, > 10000 and 1500 for NOP, μ, δ and κ receptors respectively). Longer lasting and 30-fold more potent than noc | |||
T83690 |
[Leu144, Arg147]-PLP (139-151) TFA
[Leu144, Arg147] Proteolipid Peptide (139-151),H-His-Ser-Leu-Gly-Lys-Leu-Leu-Gly-Arg-Pro-Asp-Lys-Phe-OH |
||
[Leu144,Arg147]-PLP (139-151)是髓鞘脂蛋白(PLP)的一种突变肽段,包含位于144和147位置的色氨酸到亮氨酸以及组氨酸到精氨酸的替换。使用[Leu144, Arg147]-PLP (139-151)(50 µg)乳化于完全弗氏佐剂(CFA)免疫后,能增加小鼠脾脏中的IL-4水平。它在体外抑制Th1细胞激活,但在体内不抑制,其中它诱导调节性T细胞的产生。用[Leu144, Arg147]-PLP (139-151)预免疫可以延迟由脑炎肽PLP (178-191)、髓磷脂少突细胞蛋白(MOG) (92-106)或髓鞘基础蛋白(MBP)在小鼠中诱导的实验性自身免疫性脑炎(EAE)的发病。 | |||
T83500 |
[Des-Arg10]-HOE I40
|
||
[Des-Arg10]-HOE 140 是一种有效的 B1 缓激肽受体拮抗剂,具备生物活性。 | |||
T83779 |
EP4 Antagonist 14
Prostaglandin E2 Receptor 4 Antagonist 14,PGE2 Receptor 4 Antagonist 14 |
||
EP4 antagonist 14是一种前列腺素E2(PGE2)受体亚型EP4的拮抗剂,其在使用表达人源受体的HEK293细胞的报告基因测定中的IC50值为1.1 nM。它还能抑制PGE2诱导的同种细胞中的β-阿雷斯汀招募(IC50 = 0.9 nM)。EP4 antagonist 14(10 µM)能减少RAW 264.7巨噬细胞中PGE2诱导的mRNA表达,这些mRNA编码Il-4、巨噬细胞甘露糖受体1(Mrc1)、几丁质酶样蛋白3(Chil3)、趋化因子(C-X-C)基序配体1(Cxcl1)、表达在髓样细胞上的触发受体2(Trem2)和精氨酸酶-1(Arg1)。在体内,EP4 antagonist 14(每天30 mg/kg),结合抗PD-1抗体,能够在CT26小鼠结肠癌模型中抑制肿瘤生长并增加CD8+ T细胞对肿瘤的浸润。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-02168 |
Arginase 1/ARG1 Protein, Human, Recombinant (His)
arginase 1,ARG1 |
Human | HEK293 Cells |
Arginase 1/ARG1 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 36.2 kDa and the accession number is P05089-1. | |||
TMPY-04685 |
Arginase 1/ARG1 Protein, Human, Recombinant (His & MYC)
arginase 1,ARG1 |
Human | HEK293 Cells |
Arginase 1/ARG1 Protein, Human, Recombinant (His & MYC) is expressed in HEK293 mammalian cells with His and MYC tag. The predicted molecular weight is 36.7 kDa and the accession number is P05089-1. | |||
TMPH-02524 |
Arginase-1/ARG1 Protein, Mouse, Recombinant (His)
Arginase-1,Type I arginase,Liver-... |
Mouse | P. pastoris (Yeast) |
Key element of the urea cycle converting L-arginine to urea and L-ornithine, which is further metabolized into metabolites proline and polyamides that drive collagen synthesis and bioenergetic pathways critical for cell proliferation, respectively; the urea cycle takes place primarily in the liver and, to a lesser extent, in the kidneys.; Functions in L-arginine homeostasis in nonhepatic tissues characterized by the competition between nitric oxide synthase (NOS) and arginase for the available i... | |||
TMPH-02525 |
Arginase-1/ARG1 Protein, Mouse, Recombinant (His & SUMO)
Liver-type arginase,Type I arginase,Ar... |
Mouse | E. coli |
Arginase-1/ARG1 Protein, Mouse, Recombinant (His & SUMO) is expressed in E. coli expression system with N-6xHis-SUMO tag. The predicted molecular weight is 50.8 kDa and the accession number is Q61176. |